companydata.dkcompanydata.dk

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S: Financial statements 2016

CVR: 32323502

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S (CVR 32323502) has filed annual accounts for 2016. In 2016, the company reported a gross profit of EUR 3,244,713 and a net result of EUR 3,444,680 compared with EUR 5,606,878 the year before. That is a decrease of 39.6% compared with the year before. Equity in the 2016 report amounted to EUR 14,302,410. The solvency ratio was 99.3%.

Gross Profit
EUR 3,244,713
Profit/Loss
EUR 3,444,680
Equity
EUR 14,302,410
Total Assets
EUR 14,403,559

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-3.2M EUR3.4M EUR14.3M EUR-
2015-5.4M EUR5.6M EUR10.9M EUR-
2014-5.5M EUR5.8M EUR5.3M EUR-
2013-18.5M16.3M19.1M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2016

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S: The 2015 annual report is outMay 9, 2016

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S has published its annual report for 2015. Gross profit came to DKK 5,370,361, and the net result was DKK 5,606,878.

About ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ACP 30.06.2012 1 A/S. The management consists of Jan Møller Mikkelsen. The board consists of Michael Wolff Jensen (chair), Anni Lotte Kirstine Pedersen and Jan Møller Mikkelsen. The company is owned by ASCENDIS PHARMA A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of EUR 5,567,000 and a net result of EUR -5,238,000 compared with EUR 5,001,000 the year before. Equity in the 2025 report amounted to EUR -38,639,000.

Source: annual report 2025, Danish Business Authority